R. Vandenberghe

Discipline

Psychologie (10) Histoire, Philosophie et Sociologie des sciences (2)

Discipline

Education (1)

Type de document

Articles (26)

Type de document

Articles (1)

Co-auteur

Date

Date

Source

Source

Mot-clé

Alzheimer's disease (26) Amyloid (18) Biochemical markers (18) biomarqueur (17) Human beings (15) Cerebrospinal fluid (15) maladie (14) Apolipoprotein E (14) maladie (14) âge (13) Dementia (13) Age (13) Age (13) Proteins (12) risque (11) protéine (11) information (11) Risk (11) pathologie (10) Pathology (10) Weights and measures (9) Cognition (9) Mild cognitive impairment (9) Proteomics (9) association (8) Social groups (8) Brain (8) Older people (8) plasma (8) cohorte (8)

Mot-clé

Instruction and study (1) Education (1) Assaying (1) Volume (Cubic content) (1) Teaching (1) Teachers (1) Respect (1) Necessity (Philosophy) (1) Foreign exchange (1) Emotions (Philosophy) (1) Emotions (1) Education (1) Cheek (1) Analysis (1) Influence (1) Technological innovations (1) Practice (1) Processing (1) Training of (1) Necesidad (Filosofía) (1) Cambio exterior (1) Profesores (1) Éducation (1) Analyse (1) École (1) Pédagogie (1) Innovation (1) Joue (1) Compétence (1) Éducation (1)

Documents écrit par R. Vandenberghe (26) | parle de R. Vandenberghe (1)

Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
A. Neumann et al. (4 oct. 2023)
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
F. Küçükali et al.
Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
I. de Rojas et al. (9 févr. 2023)
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.
I.E. Jansen et al.
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
A. Delvenne et al. (14 juin 2022)
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease.
P.J. Visser et al. (13 mai 2022)
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation.
A. Neumann et al.
New insights into the genetic etiology of Alzheimer's disease and related dementias.
C. Bellenguez et al.
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease.
P.J. Visser et al. (28 mars 2022)
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition.
KEJ Wesenhagen et al. (2022)
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset.
J. Homann et al. (2022)
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort.
J. Xu et al. (3 nov. 2021)
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals.
B.M. Tijms et al. (2 août 2021)
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
I. de Rojas et al. (7 juin 2021)
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
B.M. Tijms et al. (1 déc. 2020)
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset.
S. Hong et al. (22 nov. 2020)
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease.
E. Konijnenberg et al. (27 mai 2020)
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
L. Shi et al. (2020)
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
S. Westwood et al. (2020)
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
L. Shi et al.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
M. Kim et al.
Inflammatory biomarkers in Alzheimer's disease plasma.
A.R. Morgan et al.
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort.
D. Stamate et al. (2019)
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
M. Ten Kate et al. (27 sept. 2018)
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.
I. Bos et al. (6 juil. 2018)

next
Le rôle de l'enseignant dans l'innovation en éducation
Roland VANDENBERGHE (1986)